Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
The British Journal of Radiology|August 19, 2010
The future of imaging: developing the tools for monitoring response to therapy in oncology: the 2009 Sir James MacKenzie Davidson Memorial lectureE O AboagyeCancer Research|January 19, 1999
Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cellsE O Aboagye, Z M BhujwallaEuropean Journal of Cancer (Oxford, England : 1990)|October 22, 2002
PET for in vivo pharmacokinetic and pharmacodynamic measurementsN Gupta, P M Price, E O AboagyeDrug Discovery Today|March 21, 2001
In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomographyE O. Aboagye, P M. Price, T JonesAdvanced Drug Delivery Reviews|March 4, 2000
In vivo monitoring of drugs using radiotracer techniquesA Saleem, E O Aboagye, P M PriceCell Death & Disease|July 1, 2016
AKT activation controls cell survival in response to HDAC6 inhibitionM Kaliszczak, S Trousil, T Ali, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 8, 2014
Parametric imaging of ¹⁸F-fluoro-3-deoxy-3-L-fluorothymidine PET data to investigate tumour heterogeneityM Veronese, G Rizzo, E O Aboagye, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|June 12, 2004
Positron emission tomography imaging of cell proliferation in oncologyL M Kenny, E O Aboagye, P M PriceOncogene|December 2, 2014
Epigenetic changes in gastroenteropancreatic neuroendocrine tumoursP Mapelli, E O Aboagye, J Stebbing, et al.Biochemical Pharmacology|January 7, 1998
Bioreductive metabolism of the novel fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitroimidazolyl) acetamide (SR-4554)E O Aboagye, A D Lewis, M Tracy, et al.Pageof 6